Saturday 17 October 2026
Export MDVLQ’s income statement to Excel — free account
MedAvail Holdings, Inc.
MDVLQ Healthcare Pharmaceutical Retailers
Revenue growth for five consecutive years.
0.00
0.00
NaN
Follow MDVLQ
| Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '20 | Jan '20 | Dec '19 | Jan '19 | Dec '18 | Jan '18 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | — | 2 | — | 4 | — | 3 | — | 2 | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(11.84) | (12.93) | (8.17) | 2.09 | 3.22 | — | — | — | — | — |
P/S ratio |
0.45 | 2.13 | 2.07 | 6.01 | 6.16 | 6.25 | 6.20 | 28.96 | 28.16 | 15.76 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(27.66) | (37.08) | (19.61) | (27.28) | 3.64 | 2.08 | (28.28) | — | (28.51) | (35.04) |
Beneish M-Score |
(2.09) | — | 11.34 | — | 0.05 | — | 4.35 | — | 21.56 | — |
P/Operating CF |
(1.85) | (3.28) | (3.19) | (6.31) | (6.47) | (1.34) | (1.33) | (14.89) | (14.48) | (14.22) |
P/B ratio |
0.92 | 2.47 | 2.40 | 1.37 | 1.41 | 0.00 | 0.00 | 3.70 | 3.59 | 1.90 |
Price to Tangible BV |
0.94 | 2.80 | 2.73 | 1.38 | 1.42 | 0.00 | 0.00 | 6.61 | 6.43 | 3.04 |
EV/Sales |
0.30 | 1.68 | 1.63 | 2.06 | 2.21 | 7.52 | 7.47 | 28.92 | 28.12 | 14.01 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.27) | (0.87) | (0.85) | (1.00) | (1.08) | (1.45) | (1.44) | (3.20) | (3.11) | (1.95) |
EV/FCF |
(0.26) | (0.81) | (0.79) | (0.98) | (1.05) | (1.39) | (1.38) | (2.86) | (2.78) | (1.77) |
Quick Ratio |
2.41 | 2.41 | 2.84 | 2.84 | 7.82 | 7.82 | 1.21 | 1.21 | 0.06 | 0.74 |
Current Ratio |
4.03 | 4.03 | 3.65 | 3.65 | 8.39 | 8.39 | 1.84 | 1.84 | 1.78 | 1.78 |
Net Debt/EBITDA |
0.18 | 0.12 | 0.26 | 0.19 | 2.36 | 0.00 | (0.19) | 0.00 | 0.00 | 0.00 |
Debt/Assets |
14.48% | 21.35% | 25.01% | 32.11% | 3.12% | 0.00% | 69.56% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.23 | 0.34 | 0.50 | 0.64 | 0.04 | 0.00 | (0.13) | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.21 | 0.00 | 0.41 | 0.00 | 0.32 | 0.00 | 0.34 | 0.00 | 0.08 | 0.00 |
Operating CF/Net income |
1.00 | 1.00 | 0.97 | 0.97 | 1.07 | 1.07 | 0.91 | 0.91 | 1.01 | 1.01 |
Capex/Depreciation |
(0.47) | 0.00 | (1.20) | 0.00 | (0.45) | 0.00 | (0.23) | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(39.61) | (46,422.00) | (73.87) | (1,101.49) | (20.55) | (967.95) | (28.40) | 0.00 | (270.56) | — |
| (238.69%) | 0.00% | (109.35%) | 0.00% | 150.71% | 0.00% | 45.90% | 0.00% | (89.71%) | 0.00% | |
| (133.61%) | 0.00% | (81.54%) | 0.00% | (61.40%) | 0.00% | (191.76%) | 0.00% | (69.69%) | 0.00% | |
ROIC |
(214.88%) | 0.00% | (319.09%) | 0.00% | (304.64%) | 0.00% | 0.00% | 0.00% | (96.42%) | 0.00% |
Return on Tangible Assets |
(194.80%) | (179.49%) | (171.34%) | (155.87%) | (44.65%) | (43.74%) | (236.21%) | (211.81%) | (227.29%) | (227.29%) |
Average Days of Receivables |
18.70 | 18.70 | 19.61 | 19.61 | 39.72 | 39.72 | 40.27 | 40.27 | 79.08 | 1,218.69 |
Research and Development Expense of Revenue |
2.59% | 2.59% | 3.84% | 3.84% | 4.88% | 4.88% | 29.33% | 29.33% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
74.20% | 102.84% | 133.22% | 187.87% | 137.07% | 169.54% | 439.17% | 501.38% | 1,233.61% | 521.11% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.06 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.28 | 0.28 |
Share Based Compensation of Revenue |
5.33% | 0.00% | 5.45% | 0.00% | 2.72% | 0.00% | 9.39% | 0.00% | 65.28% | 0.00% |
Graham Net Nets |
0.86 | 0.18 | 0.18 | 0.66 | 0.65 | (4.27) | (4.30) | 0.12 | 0.13 | 0.29 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6,731.15 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(294.52%) | (92.36%) | (95.00%) | (57.39%) | (55.95%) | (38.54%) | (38.86%) | (31.52%) | (32.41%) | (48.96%) |
Free Cash Flow Yield |
(260.16%) | (97.42%) | (100.20%) | (35.10%) | (34.21%) | (86.29%) | (87.00%) | (34.92%) | (35.90%) | (50.33%) |
Revenue per Share |
32.77 | 32.77 | 33.88 | 33.88 | 122.10 | 122.10 | 117.11 | 117.11 | 30.25 | 30.25 |
Operating CF per Share |
(36.23) | (36.23) | (65.10) | (65.10) | (250.30) | (250.30) | (607.02) | (607.02) | (273.11) | (273.11) |
Capex per Share |
(1.75) | 0.00 | (5.04) | 0.00 | (7.14) | 0.00 | (12.48) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(37.98) | (36.23) | (70.14) | (65.10) | (257.44) | (250.30) | (619.50) | (607.02) | (273.11) | (273.11) |
Cash per Share |
9.21 | 9.21 | 30.76 | 30.76 | 506.96 | 506.96 | 274.81 | 274.81 | 1.26 | 1.26 |
Shareholders Equity per Share |
15.83 | 15.83 | 29.20 | 29.20 | 533.80 | 533.80 | (3,001.40) | (98.17) | 237.06 | 237.06 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
15.83 | 15.83 | 29.20 | 29.20 | 533.80 | 533.80 | (3,001.40) | (98.17) | 237.06 | 237.06 |
Free Cash Flow |
(49.97) | (47.66) | (45.81) | (42.52) | (29.45) | (28.63) | (19.95) | (19.55) | (3.25) | (3.25) |
Working Capital |
17.99 | 17.99 | 19.88 | 19.88 | 56.25 | 56.25 | 6.41 | 6.41 | 1.27 | 1.27 |
Capital Expenditures |
(2.30) | (2.30) | (3.29) | (3.29) | (0.82) | (0.82) | (0.40) | (0.40) | — | — |
Net Current Asset Value |
11.62 | 11.62 | 8.32 | 8.32 | 55.60 | 55.60 | (100.56) | (7.08) | 1.27 | 1.27 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.05 | 0.00 | 0.15 | 0.00 | 0.06 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.76 | 0.55 | 0.48 | 0.31 | 0.48 | 0.36 | 0.66 | 0.44 | 2.89 | 2.89 |
Cash ROIC |
(132.39%) | (119.10%) | (94.06%) | (82.71%) | (24.29%) | 0.00% | 26.50% | 0.00% | (114.60%) | 0.00% |
Accounts Receivable Turnover |
25.37 | 0.00 | 16.34 | 0.00 | 14.43 | 0.00 | 15.27 | 0.00 | 8.78 | 0.00 |
Accounts Payable Turnover |
19.52 | 0.00 | 6.24 | 0.00 | 2.57 | 0.00 | 2.19 | 0.00 | 1.20 | 0.00 |
Inventory Turnover |
7.47 | 0.00 | 6.48 | 0.00 | 2.38 | 0.00 | 0.90 | 0.00 | 0.14 | 0.00 |
Average Days of Payables |
15.09 | 13.87 | 41.45 | 63.00 | 187.04 | 46.92 | 303.20 | 33.43 | 347.34 | 35.95 |
Days of Inventory on Hand |
62.48 | 57.44 | 65.53 | 61.57 | 116.78 | 98.71 | 593.98 | 375.55 | 2,466.69 | 255.32 |
Average Receivables |
1.70 | 1.70 | 1.35 | 1.35 | 0.97 | 0.97 | 0.25 | 0.25 | 0.04 | 0.60 |
Average Payables |
2.08 | 2.08 | 3.49 | 4.26 | 3.43 | 1.84 | 1.29 | 0.32 | 0.21 | 0.21 |
Average Inventory |
5.43 | 5.43 | 3.37 | 3.37 | 3.71 | 3.71 | 3.14 | 3.14 | 1.73 | 1.73 |
Average Assets |
35.64 | 35.64 | 53.74 | 53.74 | 43.67 | 43.67 | 11.23 | 11.23 | 4.63 | 4.63 |
Average Common Equity |
19.95 | 19.95 | 40.07 | 40.07 | (17.79) | (17.79) | (46.91) | (46.91) | 3.59 | 3.59 |
Columns are period end dates